Press release
Viscosupplementation Market Anticipated To Witness Robust Growth, Surpassing $6.81 Billion By 2029
Viscosupplementation
How Big Is the Viscosupplementation Market Size Expected to Be by 2034?
The market size for viscosupplementation has experienced a swift expansion lately. The increase from $4.1 billion in 2024 to $4.55 billion in 2025 will be at a compound annual growth rate (CAGR) of 10.8%. Factors contributing to the surge during the previous period include an aging populace, escalating obesity rates, improved insurance coverage, heightened awareness, patient inclinations, and a rise in osteoarthritis cases.
The market for viscosupplementation is projected to expand significantly in the forthcoming years, reaching a value of $6.81 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 10.6%. The growth during the forecast period can be ascribed to factors such as regulatory backing, alternate payment plans, a surge in healthcare spending, progress in research and development, and expansion of indications. Leading trends during this period include the rise of outcome-driven payment methods, efforts in patient education, development in biomarkers, research in gene therapy, and adoption of value-driven care models.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9836
How Are Emerging Segments Shaping the Viscosupplementation Market Landscape?
The viscosupplementation market covered in this report is segmented -
1) By Type: Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation
2) By Source: Avian Origin, Non-Avian Origin
3) By Hyaluronic Acids: Standard Hyaluronic Acid, Stabilized Hyaluronic Acid
4) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products, Non-Hyaluronic Acid Products
2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products
3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9836&type=smp
Which Growth Factors Are Influencing Viscosupplementation Market Expansion?
The viscosupplementation market is anticipated to expand in the future due to the increasing incidence of osteoarthritis. Osteoarthritis is a degenerative joint disorder, commonly recognized as a widespread form of arthritis, where the joints primarily in the hips, knees, and hands begin to deteriorate. By injecting hyaluronic acid directly into the bone joints, viscosupplementation treatment helps reduce discomfort and promote fluid bone movement, subsequently diminishing pain and enhancing bone performance. For example, the Centers for Disease Control and Prevention (CDC), a public health organization based in the US, has predicted that by 2040, around 78.4 million adults over the age of 18 in the USA will be afflicted with arthritis. Thus, the growing prevalence of osteoarthritis helps fuel the viscosupplementation market's growth.
Who Are the Dominant Players Across Different Viscosupplementation Market Segments?
Major companies operating in the viscosupplementation market include Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd., SingHealth Group
What Are the Latest Developing Trends in the Viscosupplementation Market?
Key players in the viscosupplementation market are driving innovation by focusing on the development of original products like resorbable hyaluronic acid scaffolds. These scaffolds serve the purpose of enhancing joint lubrication, promoting tissue regeneration and providing lasting relief from the symptoms of osteoarthritis. This in turn results in improved patient outcomes and a wider range of treatments. The said resorbable hyaluronic acid scaffold is a biocompatible and biodegradable structure made mostly of hyaluronic acid (HA) which naturally exists in our connective tissues. An example of this occurred in May 2023, when Anika Therapeutics Inc., a company operating in the U.S. orthopedic sector, launched Hyalofast. This is a single-stage, off-the-shelf, resorbable hyaluronic acid scaffold designed for cartilage repair. Hyalofast aims to deliver a solution based on hyaluronic acid for the purpose of joint preservation, offering a possible alternative to more intensive surgical procedures.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/viscosupplementation-global-market-report
Which Geographic Regions Are Expected to Dominate the Viscosupplementation Market in the Coming Years?
North America was the largest region in the viscosupplementation market in 2024. The regions covered in the viscosupplementation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Viscosupplementation Market?
2. What is the CAGR expected in the Viscosupplementation Market?
3. What Are the Key Innovations Transforming the Viscosupplementation Industry?
4. Which Region Is Leading the Viscosupplementation Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Viscosupplementation Market Anticipated To Witness Robust Growth, Surpassing $6.81 Billion By 2029 here
News-ID: 3983798 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Viscosupplementation
Viscosupplementation Market Report, History and Forecast 2023-2031
Newark, New Castle, USA - Growth Plus Reports has published a new report on Viscosupplementation Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Viscosupplementation provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive and statistical…
Hampering the growth of the viscosupplementation market 2021
Viscosupplementation is a minimally invasive procedure that involves injection of the hyaluronic acid injected into a knee joint to promote better joint development and lubrication. It also helps in reducing pain, irritation and helps in improving osteoarthritis condition. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Increasing prevalence of osteoarthritis in people is expected to boost…
Understanding Impact of COVID-19 on Viscosupplementation Market
According to the report, the global viscosupplementation market was valued at ~US$ 2.6 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Viscosupplementation can be performed using three primary injection types: single injection, three injections, and five injections. Applications of viscosupplementation injection include knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis. Growth of the global viscosupplementation market can be attributed to rise in…
The three injection viscosupplementation product type segment is projected to be …
Russia’s healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation…
Viscosupplementation Market
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
Viscosupplementation Market: Three Injection Viscosupplementation Likely to be t …
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
